EVROMONT
Zapytaj lekarza o receptę na EVROMONT
Jak stosować EVROMONT
INSTRUCTIONS for medical use of the medicinal product KLIMAKTOPLAN (KLIMAKTOPLAN®)
Composition
active substances: 1 tablet contains: Cimicifuga D2 25 mg, Ignatia D3 25 mg, Sepia D2 25 mg, Sanguinaria D6 25 mg; auxiliary substances: lactose monohydrate, magnesium stearate, wheat starch.
Pharmaceutical form
Tablets.
Main physical and chemical properties
gray, biconvex tablets with a beveled edge, sometimes slightly speckled.
Pharmacotherapeutic group
Complex homeopathic preparation. Other preparations for the treatment of gynecological diseases. ATC code G02CX.
Pharmacological properties
Klimaktoplan contains four ingredients that determine the effect of the preparation. Cimicifuga affects the hypothalamus, eliminating or weakening hot flashes, nervous excitement, and depression. Sepia regulates the common functions of hormones of the adrenal cortex, sex organs, and pituitary gland. Sepia, like Ignatia, primarily acts on mental reactions, but it also affects flashes of heat, hot flashes, headaches, and a state of weakness. Sanguinaria is particularly effective in hot flashes accompanied by transient flushing and rapid heartbeat, as well as in migraine-type headaches.
Therefore, Klimaktoplan, due to the combination of specific ingredients, treats a complex of symptoms typical of the climacteric period. Thanks to its good tolerability, Klimaktoplan can be taken for a long time.
Clinical characteristics
Indications
Climacteric disorders: hot flashes, increased sweating, feeling of heartbeat, dizziness, itching, internal anxiety, sleep disturbances, depressive state, nervous excitability.
Contraindications
Increased sensitivity to the active substances or to any of the auxiliary substances of the medicinal product.
Interaction with other medicinal products and other types of interactions
Not known to date.
The use of a homeopathic medicinal product does not exclude the use of other medicinal products.
Patients should consult a doctor if they are taking or have recently taken any other medications, including medicinal products that can be purchased without a prescription.
Note. The action of homeopathic medicinal products may vary depending on general negative factors associated with harmful habits (stimulants: for example, coffee or tea, alcohol, smoking).
Special instructions
It is necessary to consult a doctor if the condition has not improved or worsened, or if additional complaints have appeared.
The medicinal product contains lactose, so patients with rare hereditary forms of galactose intolerance, lactase deficiency, or glucose-galactose malabsorption syndrome should not use it.
One of the auxiliary substances that make up the preparation is wheat starch. In connection with this, tablets should not be used by patients with increased sensitivity or intolerance to gluten.
Use during pregnancy or breastfeeding
Not used during pregnancy and breastfeeding.
Ability to affect the speed of reaction when driving vehicles or other mechanisms
Does not affect.
Method of administration and dosage
Take 1-2 tablets 3 times a day. The maximum daily dose is 6 tablets. Tablets should be taken 30 minutes before meals or 30 minutes after meals, slowly dissolving in the oral cavity. If necessary, tablets can be dissolved in a small amount of water. In case of improvement, the dosage should be reduced. Klimaktoplan should be used for at least 3 months. Treatment can be extended if necessary.
Children
Not used in children.
Overdose
Overdose has not been observed.
Adverse reactions
When using the preparation, hypersensitivity reactions are possible, menstrual and nasal bleeding may occur, or the frequency of menstrual bleeding may increase.
Note. When using homeopathic medicinal products, a temporary worsening of existing disease symptoms (primary worsening) is possible. In this case, the use of the preparation should be stopped and a doctor should be consulted.
In case of any adverse reactions, you should consult a doctor. This applies to all possible side effects, including those not described in this instruction.
Shelf life
5 years.
Do not use after the expiration date stated on the packaging.
Storage conditions
Store at a temperature not exceeding 25 ºC in a dry, inaccessible place for children.
Packaging
20 tablets in a blister pack; 3 or 5 blister packs in a cardboard box.
Release category
Without a prescription.
Manufacturer
Dr. Gustav Klein GmbH & Co. KG
Location of the manufacturer and address of the place of its activity
Steinenfeld 3, 77736 Zell am Harmersbach, Germany
- Kraj rejestracji
- Substancja czynna
- Wymaga receptyTak
- Producent
- Te informacje mają charakter wyłącznie poglądowy i nie stanowią porady medycznej. Przed zastosowaniem jakiegokolwiek leku zawsze skonsultuj się z lekarzem. Oladoctor nie ponosi odpowiedzialności za decyzje medyczne podjęte na podstawie tych treści.
- Zamienniki EVROMONTPostać farmaceutyczna: tablets, 10 tablets in a blisterSubstancja czynna: montelukastProducent: Бафна Фармасьютікалс Лтд.Wymaga receptyPostać farmaceutyczna: tablets, 4 mgSubstancja czynna: montelukastPostać farmaceutyczna: tablets, 5 mgSubstancja czynna: montelukast
Odpowiedniki EVROMONT w innych krajach
Najlepsze odpowiedniki z tą samą substancją czynną i działaniem terapeutycznym.
Odpowiednik EVROMONT – Hiszpania
Odpowiednik EVROMONT – Polska
Lekarze online w sprawie EVROMONT
Konsultacja w sprawie dawkowania, działań niepożądanych, interakcji, przeciwwskazań i odnowienia recepty na EVROMONT – decyzja należy do lekarza, zgodnie z lokalnymi przepisami.
Zapisz się na aktualizacje
Otrzymuj informacje o nowych usługach online, zmianach i ofertach dostępnych na Oladoctor w Europie.
